Researchers used stem cells from patients with idiopathic pulmonary fibrosis (IPF) to create a lung “organoid” — a three-dimensional structure similar to the human lung — that stands to improve studies into lung diseases like IPF and research into personalized drug therapies, by allowing such investigations to take place in an environment…
It’s been proven that pulmonary rehabilitation helps patients with pulmonary diseases such as chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, and pulmonary hypertension among others. Just because you have pulmonary fibrosis doesn’t mean you can’t travel by airplane. Learn more here. Providence…
Researchers suggest that a certain type of the immune system cell – called myeloid-derived suppressor cells (MDSC) – can serve as a biomarker to diagnose idiopathic pulmonary fibrosis (IPF). These cells may also distinguish stages of disease progression, as a greater loss of lung function was found in patients with higher levels of MDSCs in…
When you have pulmonary fibrosis, it is important to eat a healthy and balanced diet. Diets rich in anti-inflammatory properties and antioxidants can improve your well-being. This curry chicken salad is full of fruits and vegetables, loaded with antioxidants, and the curry acts as both an anti-inflammatory and antioxidant. Antioxidants, like…
Pulmonary fibrosis is a disease that affects the respiratory system by thickening and stiffening lung tissue, which ends up as scar tissue. In cases when physicians are unable to identify the root cause of the disease, it is called idiopathic pulmonary fibrosis. Did you know that pulmonary fibrosis can be difficult to diagnose and…
In this gripping video shared in August 2014, Elicia Shepard uses placards to demonstrate how little is known about one of the biggest killer diseases – idiopathic pulmonary fibrosis (IPF). Find out more simple facts about idiopathic pulmonary fibrosis you should know about here. Shepard shows us that…
AdAlta, a biotech that develops protein-based therapeutics, has retained FujiFilm Diosynth Biotechnologies to manufacture AD-114, AdAlta’s lead drug molecule for the treatment of idiopathic pulmonary fibrosis (IPF). AdAlta is using its proprietary technology platform to create i-bodies, a new class of protein therapeutics that are the human equivalent of the antigen-binding domain…
It’s estimated that 5 million people worldwide have idiopathic pulmonary fibrosis (IPF). The life-threatening condition primarily affects the over-50 age group, although younger people are not immune. Idiopathic means that the cause of the disease is unknown, pulmonary means lungs, and fibrosis means scarring. Simply speaking — IPF is…
Patara Pharma recently presented positive Phase 2 data on its lead candidate, PA101, for the treatment of refractory chronic cough in patients with idiopathic pulmonary fibrosis (IPF). The findings were given at the recent European Respiratory Society International Congress in London. PA101 is a late-stage immune modulator with mast…
The European Commission (EC) has granted Galapagos’ investigational product GLPG1690 orphan drug designation for the treatment of patients with idiopathic pulmonary fibrosis (IPF). GLPG1690 is a selective autotaxin inhibitor that was demonstrated to have a favorable safety and tolerability profile in a Phase 1 study in healthy volunteers. Autotaxin plays an…
Get regular updates to your inbox.
